13F-HR filed by New Leaf Venture Partners, L.L.C.
New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 15 holding rows worth $139,613,000.
- Accession
- 0001012975-17-000134
- Filer
- CIK 1631614
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 15 entries on the cover page, a total value of $139,613,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $139,613,000 with VALUE read as thousands by filing date, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERSARTIS INC | 92529L102 | COM | 2,039,223 | $30,384,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 2,344,868 | $29,311,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 1,377,497 | $20,594,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 658,259 | $17,213,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 586,475 | $11,882,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 2,059,283 | $8,958,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 114,123 | $5,827,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 177,844 | $5,394,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 228,428 | $4,751,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 2,590,673 | $1,399,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 352,950 | $1,317,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 256,381 | $1,013,000 | thousands by filing date | |
| LOMBARD MED INC | G55598109 | COM | 1,072,634 | $643,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 96,759 | $547,000 | thousands by filing date | |
| Rocket Pharmaceuticals Inc | 45780V102 | SHS | 62,300 | $380,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-17-000134 | this filing | 2017-02-14 | acceptance time not in the bulk data set |